LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,861 | 2,986 | 4,200 | 5,140 | 4,021 |
| Marketable Securities | 20,204 | 32,221 | 39,998 | 48,557 | 28,112 |
| TOTAL | $23,848 | $36,172 | $45,820 | $54,974 | $33,090 |
| Non-Current Assets | |||||
| PPE Net | 6,059 | 6,222 | 6,020 | 6,040 | 6,206 |
| Intangibles | 3,119 | 3,009 | 2,850 | 2,720 | 2,648 |
| TOTAL | $9,178 | $9,231 | $8,870 | $8,760 | $8,854 |
| Total Assets | $33,026 | $45,403 | $54,690 | $63,734 | $41,944 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,455 | 3,078 | 960 | 1,453 | 278 |
| Accrued Expenses | 3,918 | 3,631 | 2,301 | 2,578 | 3,081 |
| TOTAL | $6,309 | $7,669 | $4,172 | $4,902 | $4,176 |
| Non-Current Liabilities | |||||
| Long Term Debt | 716 | 952 | 1,092 | 1,233 | 1,312 |
| TOTAL | $716 | $952 | $1,092 | $1,247 | $1,341 |
| Total Liabilities | $7,025 | $8,621 | $5,264 | $6,149 | $5,517 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,759 | 61,400 | 61,308 | 61,211 | 61,125 |
| Common Shares | 123 | 614 | 613 | 612 | 511 |
| Retained earnings | -232,949 | -221,980 | -209,148 | -200,780 | -192,405 |
| Other shareholders' equity | -23 | -57 | -85 | -41 | -73 |
| TOTAL | $26,001 | $36,782 | $49,426 | $57,585 | $36,427 |
| Total Liabilities And Equity | $33,026 | $45,403 | $54,690 | $63,734 | $41,944 |